Intra Cellular Therapies reported $69.85M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
ALKERMES ALKS:US 139.19M 14.02M
Aptinyx Inc APTX:US $ 5.07M 94K
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biogen BIIB:US $ 637.3M 42.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cytokinetics CYTK:US $ 21.2M 5.6M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Gilead Sciences GILD:US $ 1.34B 297M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Intra Cellular Therapies ITCI:US $ 69.85M 17.27M
JAZZ PHA JAZZ:US 429.03M 168.52M
Johnson & Johnson JNJ:US $ 6.07B 641M
Marinus Pharmaceuticals MRNS:US 6.83M 3.55M
Minerva Neurosciences NERV:US $ 3.44M 806.44K
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NVS:US 3.71B 190M
Prothena PRTA:US 11.03M 93K
Redhill Biopharma RDHL:US 25.47M 4.48M
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M
United Therapeutics UTHR:US $ 112.8M 2.9M
Vanda Pharmaceuticals VNDA:US $ 28.35M 1.45M
Zogenix ZGNX:US $ 33.88M 2.61M